In the news:
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge - Canada won't be ordering Novavax's updated COVID-19 vaccine, cites low demand - Novavax Is Here for the COVID Fight: What to Know About the Vaccine - Canadian government not ordering Novavax's protein-based COVID-19 vaccine this year - What to Know About Novavax, the 'Other' COVID Vaccine - FDA authorizes Novavax's updated Covid vaccine, paving way for fall rollout - FDA authorizes Novavax's updated Covid vaccine targeting JN.1 strain - Sanofi licensing deal doubles value of vaccine group Novavax - Novavax shares nearly double on Sanofi deal to commercialize Covid vaccine, develop combination shots
NOVAVAX
Save
ShareKey facts
- city: Gaithersburg
- state: MD
- country: United States
- sector: Health Care
- foundation year: 1987
- industry: Biotechnology
- CEO: Stanley Charles Erck
Classified as: organization
Summary
NOVAVAX is a company. It is located in Gaithersburg, the United States and was founded in 1987. The company is part of the Health Care sector, specifically in the Biotechnology industry.
Business
NOVAVAX is one of the companies in the United States, companies in Biotechnology, companies in Health Care and 3,466,499 companies in our database.
- Assets: 2.6B $
- Debt: 538.6M $
- Employees: 1,541 people
- Free cash flow: -509246000 $
- Market cap: 2.3B $
- Profits: -1743750000 $
- Revenues: 1.4B $
Stocks from NOVAVAX
Explore more on business
Talking Points:
- New Era of Revolutionary Vaccines
- Meet innovative vaccine technology from Novavax. Our biotech company prevents a broad range of infectious diseases through recombinant nanoparticle technology.
- Producing next-generation vaccines with global access for more people. See what’s developing at https://t.co/apuZo0qpnM.
- Producing next-generation vaccines with global access for more people. ... Jobs at NOVAVAX INC Manager, Biostatistics ... CureVac Biotechnology Tübingen, Baden-Württemberg Johnson & Johnson Hospital & Health Care ...
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Learn more about talking points